Alpha-interferon for relapsed non-Hodgkin's lymphoma

被引：11

作者：

Armitage, A. E. ^{[1
]}

Armitage, J. D. ^{[1
]}

O Armitage, J. ^{[1
]}

机构：

[1] Univ Nebraska, Med Ctr, Dept Hematol Oncol, Omaha, NE 68182 USA

来源：

BONE MARROW TRANSPLANTATION | 2006年 / 38卷 / 10期

关键词：

D O I：

10.1038/sj.bmt.1705509

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

引用

页码：701 / 702

页数：2

共 6 条

[1]

ARMITAGE JO, 2000, ANN ONCOL, V11, P1

[2] Interferon in oncological practice: Review of interferon biology, clinical applications, and toxicities [J].

Jonasch, E ;

Haluska, FG .

ONCOLOGIST, 2001, 6 (01) :34-55

[3] Interferon-induced depression and cognitive impairment in hepatitis C virus patients: a 72 week prospective study [J].

Reichenberg, A ;

Gorman, JM ;

Dieterich, DT .

AIDS, 2005, 19 :S174-S178

[4] Longitudinal course of depression, fatigue, and quality of life in patients with high risk melanoma receiving adjuvant interferon [J].

Trask, PC ;

Paterson, AG ;

Esper, P ;

Pau, J ;

Redman, B .

PSYCHO-ONCOLOGY, 2004, 13 (08) :526-536

[5] Outcome of relapsed non-Hodgkin's lymphoma patients after allogeneic and autologous transplantation [J].

Vaishampayan, U ;

Karanes, C ;

Du, W ;

Varterasian, M ;

Al-Katib, A .

CANCER INVESTIGATION, 2002, 20 (03) :303-310

[6]

VOSE JM, 1992, BLOOD, V80, P2142

← 1 →